Figure 4.
Knockdown of miR-183-5p inhibits proliferation, migration and invasion capacity of osteosarcoma cells. (A) Expression of miR-183-5p detected in HOS and U2OS cells after transfection with miR-183-5p inhibitor and negative controls. (B) Effect of miR-183-5p knockdown on the proliferation of HOS and U2OS cells assessed by CCK-8 assays. (C) Effect of miR-183-5p knockdown on the proliferation of HOS and U2OS cells assessed by crystal violet assays; the OD values of crystal violet assays was shown in right panel. (D) Effects of miR-183-5p knockdown on the migration of HOS and U2OS cells assessed by transwell assays (magnification: 400×); the calculation of cells that migrated through the filter was shown in right panel. (E) Effects of miR-183-5p knockdown on the invasion of HOS and U2OS cells assessed by transwell assays (magnification: 400×); the calculation of cells that invaded through the filter was shown in right panel. *P< 0.05; **P< 0.01; ***P< 0.001. Data are presented as mean ± SD of three independent experiments.